InvestorsHub Logo
Followers 10
Posts 673
Boards Moderated 0
Alias Born 01/19/2014

Re: salgovernale69 post# 26122

Tuesday, 11/25/2014 7:53:37 AM

Tuesday, November 25, 2014 7:53:37 AM

Post# of 48316
It is good news, but not even in the top 2 best case scenarios. Merck is dipping their toe in the water instead of jumping in. Which is better than nothing but with Dr. Pierce on staff a little more support would have been nice. Also, ONCS does not have the money to run this trial with no extra cash and a trial for a new indication. They have shown before that they like to keep at least 12 months of operating cash on hand, so I expect to see the other 2/3 of the s-3 used in the near future.